These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 20546691)
1. Cross-reactivity of antibodies to viruses belonging to the Semliki forest serocomplex. Hassing RJ; Leparc-Goffart I; Tolou H; van Doornum G; van Genderen PJ Euro Surveill; 2010 Jun; 15(23):. PubMed ID: 20546691 [No Abstract] [Full Text] [Related]
2. Alphavirus hybrid virion vaccines. Shafferman A; Lustig S; Inbar Y; Halevy M; Schneider P; Bino T; Leitner M; Grosfeld H; Velan B; Schödel F; Cohen S Adv Exp Med Biol; 1996; 397():41-7. PubMed ID: 8718580 [No Abstract] [Full Text] [Related]
3. B cells and antibodies in the pathogenesis of myelin injury in Semliki Forest Virus encephalomyelitis. Smith-Norowitz TA; Sobel RA; Mokhtarian F Cell Immunol; 2000 Feb; 200(1):27-35. PubMed ID: 10716880 [TBL] [Abstract][Full Text] [Related]
4. Most alphaviruses share a conserved epitopic region on their nucleocapsid protein. Greiser-Wilke I; Moenning V; Kaaden OR; Figueiredo LT J Gen Virol; 1989 Mar; 70 ( Pt 3)():743-8. PubMed ID: 2471798 [TBL] [Abstract][Full Text] [Related]
5. Preliminary evidence for cell-mediated immunity in cross-protection among group A arboviruses. Peck RD; Brown A; Wust CJ J Immunol; 1975 Feb; 114(2 Pt 1):581-4. PubMed ID: 1079033 [TBL] [Abstract][Full Text] [Related]
6. CNS pathogenesis following a dual viral infection with Semliki Forest (alphavirus) and Langat (flavivirus). Amor S; Webb HE Br J Exp Pathol; 1988 Apr; 69(2):197-208. PubMed ID: 2837265 [TBL] [Abstract][Full Text] [Related]
7. In Semliki Forest virus encephalitis, antibody rapidly clears infectious virus and is required to eliminate viral material from the brain, but is not required to generate lesions of demyelination. Fragkoudis R; Ballany CM; Boyd A; Fazakerley JK J Gen Virol; 2008 Oct; 89(Pt 10):2565-2568. PubMed ID: 18796725 [TBL] [Abstract][Full Text] [Related]
8. [Survey with human sera from West Cameroon (author's transl)]. Radda A Zentralbl Bakteriol Orig A; 1973 Dec; 225(2):375-80. PubMed ID: 4150072 [No Abstract] [Full Text] [Related]
9. Simple method for preparation of immune sera to envelope and nucleocapsid antigens of Semliki Forest virus. Gaidamovich SY; Melnikova EE; Krasnobaeva ZN Acta Virol; 1977 Jul; 21(4):347-8. PubMed ID: 20771 [TBL] [Abstract][Full Text] [Related]
11. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Kägi D; Seiler P; Pavlovic J; Ledermann B; Bürki K; Zinkernagel RM; Hengartner H Eur J Immunol; 1995 Dec; 25(12):3256-62. PubMed ID: 8566009 [TBL] [Abstract][Full Text] [Related]
12. Antibody-dependent, complement-mediated homologous and cross-cytolysis of togavirus-infected cells. King B; Wust CJ; Brown A J Immunol; 1977 Oct; 119(4):1289-92. PubMed ID: 894036 [TBL] [Abstract][Full Text] [Related]
13. Protective effects of melatonin in mice infected with encephalitis viruses. Ben-Nathan D; Maestroni GJ; Lustig S; Conti A Arch Virol; 1995; 140(2):223-30. PubMed ID: 7710351 [TBL] [Abstract][Full Text] [Related]
14. The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo. Thomson M; White CL; Dimmock NJ Virology; 1998 Feb; 241(2):215-23. PubMed ID: 9499796 [TBL] [Abstract][Full Text] [Related]
15. Restricted Semliki Forest virus replication in perforin and Fas-ligand double-deficient mice. Alsharifi M; Lobigs M; Bettadapura J; Koskinen A; Müllbacher A J Gen Virol; 2008 Aug; 89(Pt 8):1942-1944. PubMed ID: 18632965 [TBL] [Abstract][Full Text] [Related]
16. The molecular pathogenesis of Semliki Forest virus: a model virus made useful? Atkins GJ; Sheahan BJ; Liljeström P J Gen Virol; 1999 Sep; 80 ( Pt 9)():2287-2297. PubMed ID: 10501479 [No Abstract] [Full Text] [Related]